Document Detail

Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder.
MedLine Citation:
PMID:  22535309     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Autism spectrum disorders (ASD) are associated with repetitive behaviours and often also with hyperactivity, aggression, self-injurious behaviour, irritability and lability of mood. There is emerging evidence that aripiprazole, an antipsychotic with partial agonist dopaminergic effect, may be effective in the treatment of these challenging behaviours. Nevertheless, there is little evidence for their efficacy in adults with ASD.
OBJECTIVES: The aim of this article is to present preliminary data on the use of aripiprazole in the treatment of challenging behaviour in the setting of ASD.
METHODS: We present a consecutive series of five inpatients of normal intelligence with challenging behaviour associated with ASD, diagnosed according to ICD-10 criteria, which was resistant to treatment with other medical and behavioural interventions and which was treated with aripiprazole.
RESULTS: Four out of five patients were classified as "much improved" or "very much improved" according to the Clinical Global Impression-Improvement scale. Aripiprazole caused akathisia, at a dose of 30 mg in the one patient who was not classified as a responder but was otherwise well tolerated.
CONCLUSIONS: This is the first case series of adults with ASD presenting with challenging behaviour who have been treated with aripiprazole. While the results are promising, controlled trials are required to confirm the findings.
Iain Jordan; Dene Robertson; Marco Catani; Michael Craig; Declan Murphy
Related Documents :
98249 - Design and evaluation of leukaemia trials.
22398509 - Role of substance abuse comorbidity and personality on the outcome of depression in bip...
22906909 - Antiplatelet therapy in stroke prevention.
20126269 - Effect of village-wide use of long-lasting insecticidal nets on visceral leishmaniasis ...
22550199 - Diagnosis and treatment of depression in adults with comorbid medical conditions: a 52-...
25363099 - The effects of vitamin b1 on ameliorating the premenstrual syndrome symptoms.
9440779 - Clinical role of soluble adhesion molecules during immunotherapy for perennial allergic...
9571469 - What is cold intolerance?
19327969 - The influence of psychiatric comorbidity on the dexamethasone/crh test in major depress...
Publication Detail:
Type:  Journal Article     Date:  2012-04-26
Journal Detail:
Title:  Psychopharmacology     Volume:  223     ISSN:  1432-2072     ISO Abbreviation:  Psychopharmacology (Berl.)     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-11     Completed Date:  2013-02-04     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  7608025     Medline TA:  Psychopharmacology (Berl)     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  357-60     Citation Subset:  IM    
Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, 16 De Crespigny Park, London, SE5 8AF, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antipsychotic Agents / administration & dosage,  therapeutic use*
Behavior / drug effects*
Child Development Disorders, Pervasive / drug therapy*,  psychology*
Piperazines / administration & dosage,  therapeutic use*
Quinolones / administration & dosage,  therapeutic use*
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Antipsychotic Agents; 0/Piperazines; 0/Quinolones; 82VFR53I78/aripiprazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cocaine self-administration behaviors in Clock?19 mice.
Next Document:  Intermittent Explosive Disorder as a Disorder of Impulsive Aggression for DSM-5.